Clinical trial
This Study Was a 8 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Curcuma Longa Extract Mixture on Immune Enhancement
NCT05324800 is registered in ClinicalTrials.gov with Chonbuk National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- This Study Was a 8 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Curcuma Longa Extract Mixture on Immune Enhancement
- Lead sponsor
- Chonbuk National University Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 4, 2022
- Completion date
- May 27, 2022
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immunity